Literature DB >> 18480301

Renal phenotype in Lowe Syndrome: a selective proximal tubular dysfunction.

Detlef Bockenhauer1, Arend Bokenkamp, William van't Hoff, Elena Levtchenko, Joana E Kist-van Holthe, Velibor Tasic, Michael Ludwig.   

Abstract

BACKGROUND AND OBJECTIVES: Lowe syndrome is defined by congenital cataracts, mental retardation, and proximal tubulopathy and is due to mutations in OCRL. Recently, mutations in OCRL were found to underlie some patients with Dent disease, characterized by low molecular weight proteinuria, hypercalciuria, and nephrocalcinosis. This phenotypic heterogeneity is poorly understood. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The renal phenotype of 16 patients with Lowe syndrome (10.9 +/- 7.0 yr) under care of the authors was characterized to define overlap of symptoms with Dent disease and infer clues about OCRL function. Medical charts of patients were reviewed for data regarding glomerular filtration rate and markers of proximal tubular function.
RESULTS: All patients had low molecular weight proteinuria and albuminuria. Lysosomal enzymuria was elevated in all 11 patients assessed. Fifteen patients had hypercalciuria, and 14 aminoaciduria. Seven patients required bicarbonate and three required phosphate replacement; all others maintained normal serum values without supplementation. None of the patients had detectable glycosuria, and none had clinically overt rickets. GFR was mildly to moderately impaired and highly variable, with a trend of deterioration with age.
CONCLUSIONS: Patients with Lowe syndrome do not have renal Fanconi syndrome but a selective proximal tubulopathy, variable in extent and dominated by low molecular weight proteinuria and hypercalciuria, the classical features of Dent disease. These findings suggest that OCRL and ClC-5, the chloride channel mutated in Dent disease, are involved in similar reabsorption pathways in the proximal tubule.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480301      PMCID: PMC2518783          DOI: 10.2215/CJN.00520108

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  28 in total

1.  Tubular proteinuria defined by a study of Dent's (CLCN5 mutation) and other tubular diseases.

Authors:  A G Norden; S J Scheinman; M M Deschodt-Lanckman; M Lapsley; J L Nortier; R V Thakker; R J Unwin; O Wrong
Journal:  Kidney Int       Date:  2000-01       Impact factor: 10.612

2.  [Lowe syndrome, study of tubular function].

Authors:  P DENYS; L CORBEEL; E EGGERMONT; H MALBRAIN
Journal:  Pediatrie       Date:  1958

3.  Organic-aciduria, decreased renal ammonia production, hydrophthalmos, and mental retardation; a clinical entity.

Authors:  C U LOWE; M TERREY; E A MacLACHLAN
Journal:  AMA Am J Dis Child       Date:  1952-02

4.  Hypercalciuria in patients with CLCN5 mutations.

Authors:  Michael Ludwig; Boris Utsch; Bernd Balluch; Stefan Fründ; Eberhard Kuwertz-Bröking; Arend Bökenkamp
Journal:  Pediatr Nephrol       Date:  2006-06-29       Impact factor: 3.714

5.  Spectrum of mutations in the OCRL1 gene in the Lowe oculocerebrorenal syndrome.

Authors:  T Lin; B M Orrison; A M Leahey; S F Suchy; D J Bernard; R A Lewis; R L Nussbaum
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

6.  Evidence for an essential role of megalin in transepithelial transport of retinol.

Authors:  E I Christensen; J O Moskaug; H Vorum; C Jacobsen; T E Gundersen; A Nykjaer; R Blomhoff; T E Willnow; S K Moestrup
Journal:  J Am Soc Nephrol       Date:  1999-04       Impact factor: 10.121

7.  Lowe syndrome protein OCRL1 interacts with clathrin and regulates protein trafficking between endosomes and the trans-Golgi network.

Authors:  Rawshan Choudhury; Aipo Diao; Fang Zhang; Evan Eisenberg; Agnes Saint-Pol; Catrin Williams; Athanasios Konstantakopoulos; John Lucocq; Ludger Johannes; Catherine Rabouille; Lois E Greene; Martin Lowe
Journal:  Mol Biol Cell       Date:  2005-05-25       Impact factor: 4.138

8.  Dent Disease with mutations in OCRL1.

Authors:  Richard R Hoopes; Antony E Shrimpton; Stephen J Knohl; Paul Hueber; Bernd Hoppe; Janos Matyus; Ari Simckes; Velibor Tasic; Burkhard Toenshoff; Sharon F Suchy; Robert L Nussbaum; Steven J Scheinman
Journal:  Am J Hum Genet       Date:  2004-12-30       Impact factor: 11.025

9.  Lysosomal enzymuria is a feature of hereditary Fanconi syndrome and is related to elevated CI-mannose-6-P-receptor excretion.

Authors:  Anthony G W Norden; Sharon C Gardner; William Van't Hoff; Robert J Unwin
Journal:  Nephrol Dial Transplant       Date:  2008-01-03       Impact factor: 5.992

10.  The renal Na+/phosphate cotransporter NaPi-IIa is internalized via the receptor-mediated endocytic route in response to parathyroid hormone.

Authors:  D Bacic; M Lehir; J Biber; B Kaissling; H Murer; C A Wagner
Journal:  Kidney Int       Date:  2006-02       Impact factor: 10.612

View more
  55 in total

1.  Mouse model for Lowe syndrome/Dent Disease 2 renal tubulopathy.

Authors:  Susan P Bothwell; Emily Chan; Isa M Bernardini; Yien-Ming Kuo; William A Gahl; Robert L Nussbaum
Journal:  J Am Soc Nephrol       Date:  2010-12-23       Impact factor: 10.121

2.  Fanconi or not Fanconi? Lowe syndrome revisited.

Authors:  Robert Kleta
Journal:  Clin J Am Soc Nephrol       Date:  2008-07-30       Impact factor: 8.237

3.  Maternal de novo triple mosaicism for two single OCRL nucleotide substitutions (c.1736A>T, c.1736A>G) in a Lowe syndrome family.

Authors:  Markus Draaken; Carmen A Giesen; Anne L Kesselheim; Ronald Jabs; Stefan Aretz; Monika Kugaudo; Krystyna H Chrzanowska; Malgorzata Krajewska-Walasek; Michael Ludwig
Journal:  Hum Genet       Date:  2011-01-12       Impact factor: 4.132

Review 4.  The blind kidney: disorders affecting kidneys and eyes.

Authors:  Isabelle Russell-Eggitt; Detlef Bockenhauer
Journal:  Pediatr Nephrol       Date:  2013-01-24       Impact factor: 3.714

5.  Abnormal bradykinin signalling in fibroblasts deficient in the PIP(2) 5-phosphatase, ocrl1.

Authors:  S F Suchy; J C Cronin; R L Nussbaum
Journal:  J Inherit Metab Dis       Date:  2009-01-28       Impact factor: 4.982

6.  The ratio of urinary α1-microglobulin to microalbumin can be used as a diagnostic criterion for tubuloproteinuria.

Authors:  Hongwen Zhang; Fang Wang; Huijie Xiao; Yong Yao
Journal:  Intractable Rare Dis Res       Date:  2018-02

7.  Characterization of 28 novel patients expands the mutational and phenotypic spectrum of Lowe syndrome.

Authors:  Florian Recker; Marcin Zaniew; Detlef Böckenhauer; Nunzia Miglietti; Arend Bökenkamp; Anna Moczulska; Anna Rogowska-Kalisz; Guido Laube; Valerie Said-Conti; Belde Kasap-Demir; Anna Niemirska; Mieczysław Litwin; Grzegorz Siteń; Krystyna H Chrzanowska; Małgorzata Krajewska-Walasek; Sidharth K Sethi; Velibor Tasic; Franca Anglani; Maria Addis; Anna Wasilewska; Maria Szczepańska; Krzysztof Pawlaczyk; Przemysław Sikora; Michael Ludwig
Journal:  Pediatr Nephrol       Date:  2014-12-06       Impact factor: 3.714

8.  The 5-phosphatase OCRL mediates retrograde transport of the mannose 6-phosphate receptor by regulating a Rac1-cofilin signalling module.

Authors:  Vanessa A van Rahden; Kristina Brand; Juliane Najm; Joerg Heeren; Suzanne R Pfeffer; Thomas Braulke; Kerstin Kutsche
Journal:  Hum Mol Genet       Date:  2012-08-19       Impact factor: 6.150

Review 9.  Acidosis and Urinary Calcium Excretion: Insights from Genetic Disorders.

Authors:  R Todd Alexander; Emmanuelle Cordat; Régine Chambrey; Henrik Dimke; Dominique Eladari
Journal:  J Am Soc Nephrol       Date:  2016-07-28       Impact factor: 10.121

10.  Clinical and molecular aspects of distal renal tubular acidosis in children.

Authors:  Martine T P Besouw; Marc Bienias; Patrick Walsh; Robert Kleta; William G Van't Hoff; Emma Ashton; Lucy Jenkins; Detlef Bockenhauer
Journal:  Pediatr Nephrol       Date:  2017-02-10       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.